Maria Irno Consalvo - Concepedia

Author

Maria Irno Consalvo

Also Known As

Alfredo De Lauro, M Consalvo, M I Consalvo, M Irno Consalvo, M. I. Consalvo, M. Irno Consalvo, Maria Irno Consalvo, Maria irno Consalvo

Publications

898

Citations

H-Index

Concepts

All Affiliations

University of Rome Tor Vergata Fondazione Santa Lucia St. Eugenio Hospital Fondazione Gimema Onlus Centro di Riferimento Oncologico

About

Maria Irno Consalvo is an author at University of Rome Tor Vergata specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	343
2	Health Sciences	2	2	204
3	Natural Sciences	1	1	24
4	Biochemistry	1	1	24
5	Blood Transplantation	1	1	72

Maria Irno Consalvo

Publications

757

Citations

H-Index

Page 1

	Year	Citations
The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia Francesco Buccisano, Luca Maurillo, Valter Gattei, Leukemia Hematological MalignancyOncologyMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaPrognosis	2006	132
Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia Francesco Buccisano, Luca Maurillo, Alessandra Spagnoli, Blood	2010	131
Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow Luca Maurillo, Francesco Buccisano, Alessandra Spagnoli, Haematologica	2007	89
A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies <i>FLT3</i> -Mutated Clones in Acute Myeloid Leukemia Daniela F. Angelini, Tiziana Ottone, Gisella Guerrera, Clinical Cancer Research	2015	81
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation Adriano Venditti, Luca Maurillo, Francesco Buccisano, Leukemia Hematological MalignancyTransplantationMarrow TransplantationMedicineAcute Myeloid Leukemia	2003	72
A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemias Alicja Gruszka, Serena Lavorgna, Maria Irno Consalvo, Blood	2010	39
High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma Maria Ilaria Del Principe, Francesco Buccisano, Mariagiovanna Cefalo, Annals of Hematology Flow CytometryLymphoid NeoplasiaHigh SensitivityMedicineMalignant Blood Disorder	2014	39
Minimal residual disease negativity in elderly patients with acute myeloid leukemia may indicate different postremission strategies than in younger patients Francesco Buccisano, Luca Maurillo, Alfonso Piciocchi, Annals of Hematology Hematological MalignancyDifferent Postremission StrategiesAgingElderly PatientsGeriatrics	2015	33
The poly(ADP-ribose) polymerase inhibitor olaparib induces up-regulation of death receptors in primary acute myeloid leukemia blasts by NF-κB activation Isabella Faraoni, Francesca M. Aloisio, Antonio De Gabrieli, Cancer Letters Hematological MalignancyOncologyMedicineApoptosisImmunology	2018	26
Cytochrome c-induced cytosolic nicotinamide adenine dinucleotide oxidation, mitochondrial permeability transition, and apoptosis Gianluigi La Piana, Domenico Marzulli, Maria Irno Consalvo, Archives of Biochemistry and Biophysics Mitochondrial FunctionBiochemistryMedicineNatural SciencesApoptosis	2003	24

Page 1